出版：MarketsandMarkets（マーケッツアンドマーケッツ） 出版年月：2024年4月
Hemodialysis and Peritoneal Dialysis Market – Global Forecast to 2029
血液透析＆腹膜透析市場 : 製品［機械、血液系、濃縮液（アルカリ性）、カテーテル、透析器、水処理、サービス］、モダリティ（CAPD、オーバーナイト）、ユーザー（病院、在宅医療）＆地域別の規模 – 2029年までの世界予測
Hemodialysis and Peritoneal Dialysis Market Size by Product (Machine, Bloodline, Concentrate (Alkaline), Catheter, Dialyzer, Water Treatment, Services), Modality (CAPD, Nocturnal), User (Hospital, Home Care) & Region – Global Forecast to 2029
| ページ数 | 305 |
| 図表数 | 415 |
| 価格 | |
| シングルユーザライセンス | USD 4,950 |
| マルチユーザライセンス（5名） | USD 6,650 |
| コーポレートライセンス | USD 8,150 |
| エンタープライズサイトライセンス | USD 10,000 |
| 種別 | 英文調査報告書 |
Report Overview
The global hemodialysis and peritoneal dialysis market is projected to reach USD 126.2 billion by 2029 from USD 92.0 billion in 2024 at a CAGR of 6.5% during the forecast period.
世界の血液透析＆腹膜透析市場は、予測期間中に6.5%のCAGRで、2024年の920億米ドルから2029年までに1,262億米ドルに達すると予測されています。
The rapid growth in the geriatric population globally and the significant rise in the patients’ kidney-related diseases are expected to boost the demand for the Hemodialysis and peritoneal dialysis market. Moreover, gradual rise in utilization of home hemodialysis is likely to support the market growth. Advancements in dialysis treatment technology and government policies, investments in healthcare infrastructure, and initiatives to enhance the accessibility of dialysis services are anticipated to fuel the market growth.
“The hemodialysis services segment of hemodialysis products and services market to grow with the highest CAGR during the forecast period.”
Based on the hemodialysis products and services market, the hemodialysis services segment is anticipated to grow at a significant rate during the forecast period. This is attributed to the rising demand for hemodialysis treatment among patients with end stage renal disease and the growth of hemodialysis service providers, focusing on extending the hemodialysis services offered through the collaboration with many dialysis centers to meet the increasing demand and improve patient outcomes.
“The End Stage Renal Disease (ESRD) segment to capture the largest market share of hemodialysis and peritoneal dialysis market.”
Based on disease indication the Hemodialysis and peritoneal dialysis market are segmented into acute kidney Injury (AKI), End end-stage renal Disease (ESRD) and other disease indications including electrolyte imbalance, fluid overload, and poisoning. The ESRD segment held the largest market share during the forecast period. The rising incidence of chronic conditions such as diabetes, hypertension and the growing prevalence of chronic kidney disease are leading to the larger pool of patients at a risk of developing ESRD. Improved access to healthcare services in developing countries and the growing awareness about the kidney disease and the increasing utilization of Hemodialysis treatment for ESRD management are likely to support the growth of the segment.
“North America accounted for the largest share of the hemodialysis and peritoneal dialysis market by region.”
The global hemodialysis and peritoneal dialysis market is segmented into five major regions, namely, North America, Europe, Asia Pacific, Latin America, and Middle East & Africa. North America is the largest regional market for hemodialysis and peritoneal dialysis products and services, whereas the Asia Pacific market is estimated to grow at the highest CAGR during the forecast period.
The largest share of North America can be attributed to the high disease burden of chronic kidney disease contributing to a larger pool of patients requiring hemodialysis and peritoneal dialysis treatment. The presence of numerous dialysis services providers, increasing number of dialysis centers in North America offering hemodialysis, peritoneal dialysis, and home dialysis services, and favorable reimbursement policy in the region is likely to promote the growth of hemodialysis and peritoneal dialysis market in North America.
A breakdown of the primary participants referred to for this report is provided below:
- By Company Type: Tier 1–25%, Tier 2–30%, and Tier 3– 45%
- By Designation: C-level–26%, Director-level–30%, and Others–44%
- By Region: North America–40%, Europe–31%, Asia Pacific–20%, Latin America–6%, and the Middle East & Africa–3%
The major players operating in the hemodialysis and peritoneal dialysis market market are Fresenius Medical Care AG & Co. KGaA (Germany), Baxter International, Inc. (US), Braun Melsungen AG (Germany), Nipro Corporation (Japan), DaVita Inc. (US), Nikkiso Co., Ltd. (Japan), Asahi Kasei Corporation (Japan), Cantel Medical Corporation (US), Diaverum (Germany).
Research Coverage
This report studies the hemodialysis and peritoneal dialysis market based on hemodialysis and peritoneal dialysis products and services, disease indication, end user and region. The report also studies factors (such as drivers, restraints, opportunities, and challenges) affecting market growth and provides details of the competitive landscape for market leaders. Furthermore, the report analyzes micro markets with respect to their individual growth trends and forecasts the revenue of the market segments with respect to five major regions (and the respective countries in these regions).
Reasons to Buy the Report
The report will enable established firms as well as entrants/smaller firms to gauge the pulse of the market, which, in turn, would help them to garner a larger market share. Firms purchasing the report could use one or a combination of the below-mentioned strategies for strengthening their market presence.
This report provides insights on the following pointers:
Analysis of Key divers (increasing number of ESRD patients, technological advancement in hemodialysis and peritoneal dialysis equipment, growing prevalence of diabetes and hypertension ), restraints (high cost of hemodialysis treatment, reimbursement concerns in emerging countries, complication associated with dialysis procedure), Opportunities (emerging markets, gradual shift towards home hemodialysis ), Challenge (Product recall)
Market Penetration: Comprehensive information on the product portfolios offered by the top players in the hemodialysis and peritoneal dialysis market
Product Development/Innovation: Detailed insights on the upcoming trends, R&D activities, and product launches in the hemodialysis and peritoneal dialysis market
Market Development: Comprehensive information on lucrative emerging regions
Market Diversification: Exhaustive information about new products, growing geographies, and recent developments in the hemodialysis and peritoneal dialysis market
Competitive Assessment: In-depth assessment of market segments, growth strategies, revenue analysis, and products of the leading market players.
Table of Contents
1 INTRODUCTION 29
1.1 STUDY OBJECTIVES 29
1.2 MARKET DEFINITION 29
1.3 INCLUSIONS & EXCLUSIONS 30
1.4 STUDY SCOPE 32
1.4.1 MARKETS COVERED 32
FIGURE 1 HEMODIALYSIS AND PERITONEAL DIALYSIS MARKET: SEGMENTS COVERED 32
1.4.2 REGIONS COVERED 33
FIGURE 2 HEMODIALYSIS AND PERITONEAL DIALYSIS MARKET: REGIONS COVERED 33
1.4.3 YEARS CONSIDERED 33
1.4.4 CURRENCY CONSIDERED 34
TABLE 1 STANDARD CURRENCY CONVERSION RATES 34
1.5 STAKEHOLDERS 34
1.6 SUMMARY OF CHANGES 34
1.6.1 RECESSION IMPACT 35
2 RESEARCH METHODOLOGY 36
2.1 RESEARCH DATA 36
FIGURE 3 RESEARCH DESIGN: HEMODIALYSIS AND PERITONEAL DIALYSIS MARKET 36
2.1.1 SECONDARY DATA 37
FIGURE 4 INDICATIVE LIST OF SECONDARY SOURCES 38
2.1.2 PRIMARY DATA 39
FIGURE 5 LIST OF KEY PRIMARY SOURCES 39
FIGURE 6 KEY INDUSTRY INSIGHTS 40
FIGURE 7 BREAKDOWN OF PRIMARY INTERVIEWS: BY COMPANY TYPE, DESIGNATION, AND REGION 40
2.2 MARKET SIZE ESTIMATION 41
2.2.1 REVENUE MAPPING-BASED MARKET ESTIMATION 41
2.2.2 USAGE-BASED MARKET ESTIMATION 41
FIGURE 8 ESTIMATION OF HEMODIALYSIS AND PERITONEAL DIALYSIS PROCEDURES, BY COUNTRY/REGION 42
FIGURE 9 MARKET SIZE ESTIMATION: HEMODIALYSIS AND PERITONEAL DIALYSIS MARKET, BY PRODUCT UTILIZATION METHODOLOGY 42
FIGURE 10 MARKET SIZE ESTIMATION: HEMODIALYSIS AND PERITONEAL DIALYSIS SERVICES MARKET, BY REVENUE MAPPING METHODOLOGY 43
2.2.3 PRIMARY RESEARCH VALIDATION 43
2.3 MARKET BREAKDOWN & DATA TRIANGULATION 44
FIGURE 11 DATA TRIANGULATION METHODOLOGY 44
2.4 MARKET RANKING ANALYSIS 45
2.5 STUDY ASSUMPTIONS 45
2.6 RISK ASSESSMENT 45
2.7 RESEARCH LIMITATIONS 45
2.8 IMPACT OF ECONOMIC RECESSION ON HEMODIALYSIS AND PERITONEAL DIALYSIS MARKET 46
TABLE 2 GLOBAL INFLATION RATE PROJECTION, 2021–2027 (% GROWTH) 46
3 EXECUTIVE SUMMARY 47
FIGURE 12 HEMODIALYSIS MARKET, BY PRODUCT & SERVICE, 2024 VS. 2029 (USD BILLION) 47
FIGURE 13 PERITONEAL DIALYSIS MARKET, BY PRODUCT & SERVICE, 2024 VS. 2029 (USD BILLION) 48
FIGURE 14 HEMODIALYSIS AND PERITONEAL DIALYSIS MARKET, BY END USER, 2024 VS. 2029 (USD BILLION) 48
FIGURE 15 GEOGRAPHICAL SNAPSHOT OF HEMODIALYSIS AND PERITONEAL DIALYSIS MARKET 49
4 PREMIUM INSIGHTS 50
4.1 HEMODIALYSIS AND PERITONEAL DIALYSIS MARKET OVERVIEW 50
FIGURE 16 RISING PREVALENCE OF END-STAGE RENAL DISEASE AND GROWING AWARENESS ABOUT DIALYSIS TREATMENT TO DRIVE MARKET 50
4.2 HEMODIALYSIS MARKET, BY PRODUCT & SERVICE, 2024 VS. 2029 (USD BILLION) 51
FIGURE 17 HEMODIALYSIS CONSUMABLES & SUPPLIES TO REGISTER HIGHEST CAGR DURING FORECAST PERIOD 51
4.3 HEMODIALYSIS MARKET, BY MODALITY, 2024 VS. 2029 (USD BILLION) 51
FIGURE 18 CONVENTIONAL LONG-TERM HEMODIALYSIS TO COMMAND LARGEST MARKET SHARE DURING STUDY PERIOD 51
4.4 ASIA PACIFIC: HEMODIALYSIS AND PERITONEAL DIALYSIS MARKET, BY TYPE AND COUNTRY (2023) 52
FIGURE 19 JAPAN AND PERITONEAL DIALYSIS CONCENTRATES/DIALYSATES ACCOUNTED FOR LARGEST MARKET SHARE IN 2023 52
4.5 HEMODIALYSIS AND PERITONEAL DIALYSIS MARKET: GEOGRAPHICAL GROWTH OPPORTUNITIES 53
FIGURE 20 CHINA TO REGISTER HIGHEST GROWTH RATE DURING FORECAST PERIOD 53
5 MARKET OVERVIEW 54
5.1 INTRODUCTION 54
5.2 MARKET DYNAMICS 54
FIGURE 21 HEMODIALYSIS AND PERITONEAL DIALYSIS MARKET: DRIVERS, RESTRAINTS, OPPORTUNITIES, AND CHALLENGES 54
5.2.1 DRIVERS 55
5.2.1.1 Rising prevalence of chronic kidney diseases 55
FIGURE 22 CANADA: NUMBER OF TOTAL INCIDENTS OF END-STAGE RENAL DISEASE PATIENTS, BY AGE GROUP (2022) 55
TABLE 3 NUMBER OF PEOPLE AGED 65 YEARS OR OVER, BY REGION, 2012 VS. 2050 56
5.2.1.2 Growing prevalence of diabetes and hypertension 56
FIGURE 23 US: REPORTED CAUSES OF END-STAGE RENAL DISEASES, 2023 56
5.2.1.3 Technological advancements and increased investment in R&D 57
5.2.2 RESTRAINTS 57
5.2.2.1 Risks and complications of dialysis treatments 57
5.2.2.2 High procedural cost of dialysis 58
5.2.3 OPPORTUNITIES 58
5.2.3.1 Increasing growth opportunities in emerging economies 58
FIGURE 24 INCIDENCE OF TREATED END-STAGE RENAL DISEASE PATIENTS, 2021 59
5.2.3.2 Rising number of dialysis centers 59
5.2.3.3 Growing preference for home hemodialysis 60
5.2.4 CHALLENGES 61
5.2.4.1 Increasing number of product recalls 61
5.2.4.2 Shortage of skilled nephrologists and lack of training programs in low-income countries 61
5.3 REGULATORY LANDSCAPE 62
5.3.1 REGULATORY ANALYSIS 62
5.3.1.1 North America 62
5.3.1.1.1 US 62
5.3.1.1.2 Canada 62
5.3.1.2 Europe 62
5.3.1.3 Asia Pacific 63
5.3.1.3.1 India 63
5.3.1.3.2 China 63
5.3.1.3.3 Japan 63
5.3.1.3.4 South Korea 63
5.3.1.4 Latin America 63
5.3.1.4.1 Brazil 64
5.3.1.4.2 Mexico 64
5.3.1.5 Middle East 64
5.3.1.6 Africa 65
5.3.2 REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS 65
TABLE 4 NORTH AMERICA: REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS 65
TABLE 5 EUROPE: REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS 65
TABLE 6 ASIA PACIFIC: REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS 66
TABLE 7 LATIN AMERICA: REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS 66
TABLE 8 MIDDLE EAST & AFRICA: REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS 66
5.4 REIMBURSEMENT ANALYSIS 67
TABLE 9 MEDICAL REIMBURSEMENT CODES FOR HEMODIALYSIS AND PERITONEAL DIALYSIS PROCEDURES 67
5.4.1 NORTH AMERICA 67
5.4.2 EUROPE 68
5.4.2.1 Germany 69
5.4.2.2 France 69
5.4.2.3 UK 69
5.4.3 ASIA PACIFIC 69
5.4.3.1 India 70
5.4.3.2 China 70
5.4.3.3 Japan 70
5.4.3.4 Pacific Region 71
5.4.3.5 Other Asia Pacific Countries 71
5.5 ECOSYSTEM/MARKET MAP 71
5.6 VALUE CHAIN ANALYSIS 72
FIGURE 25 HEMODIALYSIS AND PERITONEAL DIALYSIS MARKET: VALUE CHAIN ANALYSIS 72
5.7 SUPPLY CHAIN ANALYSIS 72
FIGURE 26 HEMODIALYSIS AND PERITONEAL DIALYSIS MARKET: SUPPLY CHAIN ANALYSIS 73
5.8 TECHNOLOGY ANALYSIS 73
5.8.1 KEY TECHNOLOGIES 73
5.8.1.1 Portable hemodialysis 73
5.8.2 COMPLEMENTARY TECHNOLOGIES 74
5.8.2.1 Biocompatible dialysis membrane 74
5.8.2.2 Connected health and remote sensors 74
5.8.3 ADJACENT TECHNOLOGIES 74
5.8.3.1 Wearable artificial kidney 74
5.9 PATENT ANALYSIS 75
5.9.1 PATENT PUBLICATION TRENDS FOR HEMODIALYSIS AND PERITONEAL DIALYSIS MARKET 75
FIGURE 27 GLOBAL NUMBER OF PATENT PUBLICATIONS (JANUARY 2013–MARCH 2024) 75
5.9.2 INSIGHTS: JURISDICTION AND TOP APPLICANT ANALYSIS 75
FIGURE 28 TOP APPLICANTS & OWNERS (COMPANIES/INSTITUTIONS) FOR HEMODIALYSIS MACHINE PATENTS (JANUARY 2013–MARCH 2024) 76
FIGURE 29 TOP APPLICANTS & OWNERS (COMPANIES/INSTITUTIONS) FOR PERITONEAL DIALYSIS CYCLER PATENTS (JANUARY 2013–MARCH 2024) 77
FIGURE 30 TOP APPLICANTS & OWNERS (COMPANIES/INSTITUTIONS) FOR HEMODIALYSIS DIALYSATE PATENTS (JANUARY 2013–MARCH 2024) 78
5.10 PRICING ANALYSIS 79
TABLE 10 AVERAGE PRICE OF HEMODIALYSIS AND PERITONEAL DIALYSIS SYSTEMS AND CONSUMABLES IN 2022, BY COUNTRY (USD) 79
TABLE 11 AVERAGE SELLING PRICE OF HEMODIALYSIS & PERITONEAL DIALYSIS PRODUCTS AND CONSUMABLES, BY KEY PLAYER (USD) 79
5.11 TRADE ANALYSIS 80
TABLE 12 IMPORT DATA FOR HEMODIALYSIS AND PERITONEAL DIALYSIS PRODUCTS AND CONSUMABLES (HS CODE 901890), BY COUNTRY, 2019–2023 (USD THOUSAND) 80
TABLE 13 EXPORT DATA FOR HEMODIALYSIS AND PERITONEAL DIALYSIS PRODUCTS AND CONSUMABLES (HS CODE 901890), BY COUNTRY, 2019–2023 (USD THOUSAND) 81
5.12 PORTER’S FIVE FORCES ANALYSIS 81
TABLE 14 HEMODIALYSIS AND PERITONEAL DIALYSIS MARKET: PORTER’S FIVE FORCES ANALYSIS 81
5.12.1 THREAT OF NEW ENTRANTS 81
5.12.2 THREAT OF SUBSTITUTES 82
5.12.3 BARGAINING POWER OF SUPPLIERS 82
5.12.4 BARGAINING POWER OF BUYERS 82
5.12.5 INTENSITY OF COMPETITIVE RIVALRY 82
5.13 KEY CONFERENCES & EVENTS, 2024–2025 83
TABLE 15 HEMODIALYSIS AND PERITONEAL DIALYSIS MARKET: DETAILED LIST OF KEY CONFERENCES & EVENTS, 2024–2025 83
5.14 KEY STAKEHOLDERS & BUYING CRITERIA 84
5.14.1 KEY STAKEHOLDERS IN BUYING PROCESS 84
FIGURE 31 INFLUENCE OF STAKEHOLDERS ON BUYING PROCESS FOR HEMODIALYSIS AND PERITONEAL DIALYSIS PRODUCTS 84
TABLE 16 INFLUENCE OF KEY STAKEHOLDERS ON BUYING PROCESS FOR HEMODIALYSIS AND PERITONEAL DIALYSIS PRODUCTS 84
5.14.2 KEY BUYING CRITERIA 85
FIGURE 32 KEY BUYING CRITERIA FOR HEMODIALYSIS AND PERITONEAL DIALYSIS PRODUCTS 85
TABLE 17 BUYING CRITERIA FOR HEMODIALYSIS AND PERITONEAL DIALYSIS PRODUCTS 85
5.15 INVESTMENT & FUNDING SCENARIO 86
FIGURE 33 INVESTMENT AND FUNDING SCENARIO FOR HEMODIALYSIS AND PERITONEAL DIALYSIS MARKET PLAYERS 86
6 HEMODIALYSIS MARKET, BY PRODUCT & SERVICE 87
6.1 INTRODUCTION 88
TABLE 18 HEMODIALYSIS MARKET, BY PRODUCT & SERVICE, 2022–2029 (USD BILLION) 88
6.2 HEMODIALYSIS SERVICES 88
TABLE 19 HEMODIALYSIS MARKET FOR HEMODIALYSIS SERVICES, BY TYPE, 2022–2029 (USD BILLION) 89
TABLE 20 HEMODIALYSIS MARKET FOR HEMODIALYSIS SERVICES, BY REGION, 2022–2029 (USD BILLION) 89
6.2.1 IN-CENTER HEMODIALYSIS SERVICES 89
6.2.1.1 Growing geriatric population and increasing government healthcare expenditure to drive segment 89
TABLE 21 IN-CENTER HEMODIALYSIS SERVICES MARKET, BY REGION, 2022–2029 (USD BILLION) 90
6.2.2 HOME HEMODIALYSIS SERVICES 90
6.2.2.1 Poor reimbursement scenario and high treatment costs to limit market growth 90
TABLE 22 HOME HEMODIALYSIS SERVICES MARKET, BY REGION, 2022–2029 (USD BILLION) 91
6.3 HEMODIALYSIS PRODUCTS 91
TABLE 23 HEMODIALYSIS MARKET FOR HEMODIALYSIS PRODUCTS, BY TYPE, 2022–2029 (USD BILLION) 91
TABLE 24 HEMODIALYSIS MARKET FOR HEMODIALYSIS PRODUCTS, BY REGION, 2022–2029 (USD BILLION) 92
6.3.1 HEMODIALYSIS MACHINES 92
TABLE 25 HEMODIALYSIS MACHINES MARKET, BY TYPE, 2022–2029 (USD BILLION) 92
TABLE 26 HEMODIALYSIS MACHINES MARKET, BY REGION, 2022–2029 (USD BILLION) 93
6.3.1.1 Center-use hemodialysis machines 93
6.3.1.1.1 Rising number of renal care centers to aid segment growth 93
TABLE 27 CENTER-USE HEMODIALYSIS MACHINES MARKET, BY REGION, 2022–2029 (USD BILLION) 93
6.3.1.2 Home-use hemodialysis machines 94
6.3.1.2.1 Lesser hospital stays and better clinical outcomes to propel segment growth 94
TABLE 28 HOME-USE HEMODIALYSIS MACHINES MARKET, BY REGION, 2022–2029 (USD BILLION) 94
6.3.2 HEMODIALYSIS CONSUMABLES & SUPPLIES 94
TABLE 29 HEMODIALYSIS CONSUMABLES & SUPPLIES MARKET, BY TYPE, 2022–2029 (USD BILLION) 95
TABLE 30 HEMODIALYSIS CONSUMABLES & SUPPLIES MARKET, BY REGION, 2022–2029 (USD BILLION) 95
6.3.2.1 Dialyzers 95
TABLE 31 DIALYZERS MARKET, BY REGION, 2022–2029 (USD BILLION) 96
6.3.2.1.1 Dialyzers market, by material 96
TABLE 32 DIALYZERS MARKET, BY MATERIAL, 2022–2029 (USD BILLION) 96
6.3.2.1.1.1 Synthetic dialyzers 97
TABLE 33 SYNTHETIC DIALYZERS MARKET, BY REGION, 2022–2029 (USD BILLION) 97
6.3.2.1.1.2 Cellulose-based dialyzers 97
TABLE 34 CELLULOSE-BASED DIALYZERS MARKET, BY REGION, 2022–2029 (USD BILLION) 98
6.3.2.1.2 Dialyzers market, by flux 98
TABLE 35 DIALYZERS MARKET, BY FLUX, 2022–2029 (USD BILLION) 98
6.3.2.1.2.1 High-flux dialyzers 99
TABLE 36 HIGH-FLUX DIALYZERS MARKET, BY REGION, 2022–2029 (USD BILLION) 99
6.3.2.1.2.2 Low-flux dialyzers 99
TABLE 37 LOW-FLUX DIALYZERS MARKET, BY REGION, 2022–2029 (USD BILLION) 100
6.3.2.2 Bloodlines 100
6.3.2.2.1 High pricing and reduced rate of reuse to limit market 100
TABLE 38 BLOODLINES MARKET, BY REGION, 2022–2029 (USD BILLION) 100
6.3.2.3 Concentrates/Dialysates 101
TABLE 39 CONCENTRATES/DIALYSATES MARKET, BY TYPE, 2022–2029 (USD BILLION) 101
TABLE 40 CONCENTRATES/DIALYSATES MARKET, BY REGION, 2022–2029 (USD BILLION) 101
6.3.2.3.1 Alkaline concentrates 102
6.3.2.3.1.1 Growing consumption before dialysis to boost segment growth 102
TABLE 41 ALKALINE CONCENTRATES MARKET, BY REGION, 2022–2029 (USD BILLION) 102
6.3.2.3.2 Acidic concentrates 102
6.3.2.3.2.1 Increased number of side effects to limit segment growth 102
TABLE 42 ACIDIC CONCENTRATES MARKET, BY REGION, 2022–2029 (USD BILLION) 103
6.3.2.4 Access products 103
TABLE 43 ACCESS PRODUCTS MARKET, BY TYPE, 2022–2029 (USD BILLION) 103
TABLE 44 ACCESS PRODUCTS MARKET, BY REGION, 2022–2029 (USD BILLION) 104
6.3.2.4.1 AV fistula needles 104
6.3.2.4.1.1 Better blood flow and lower infection risk to aid segment growth 104
TABLE 45 AV FISTULA NEEDLES MARKET, BY REGION, 2022–2029 (USD BILLION) 105
6.3.2.4.2 AV grafts 105
6.3.2.4.2.1 Increased number of patients requiring long-term dialysis to support segment growth 105
TABLE 46 AV GRAFTS MARKET, BY REGION, 2022–2029 (USD BILLION) 106
6.3.2.4.3 Central venous catheters 106
6.3.2.4.3.1 Increased use in temporary vascular access for short-term dialysis to boost segment growth 106
TABLE 47 CENTRAL VENOUS CATHETERS MARKET, BY REGION, 2022–2029 (USD BILLION) 107
6.3.2.5 Other hemodialysis consumables & supplies 107
TABLE 48 OTHER HEMODIALYSIS CONSUMABLES & SUPPLIES MARKET, BY REGION, 2022–2029 (USD BILLION) 107
6.4 HEMODIALYSIS MARKET, BY MODALITY 108
TABLE 49 HEMODIALYSIS MARKET, BY MODALITY, 2022–2029 (USD BILLION) 108
6.4.1 CONVENTIONAL LONG-TERM HEMODIALYSIS 108
6.4.1.1 Technological advancements and rising number of dialysis centers to drive segment 108
TABLE 50 HEMODIALYSIS MARKET FOR CONVENTIONAL LONG-TERM HEMODIALYSIS, BY REGION, 2022–2029 (USD BILLION) 109
6.4.2 SHORT DAILY HEMODIALYSIS 109
6.4.2.1 Improved blood pressure control and better calcium-phosphorus balance to augment segment growth 109
TABLE 51 HEMODIALYSIS MARKET FOR SHORT DAILY HEMODIALYSIS, BY REGION, 2022–2029 (USD BILLION) 110
6.4.3 NOCTURNAL HEMODIALYSIS 110
6.4.3.1 Lower procedure costs to aid segment growth 110
TABLE 52 HEMODIALYSIS MARKET FOR NOCTURNAL HEMODIALYSIS, BY REGION, 2022–2029 (USD BILLION) 111
6.5 WATER TREATMENT SYSTEMS MARKET, BY TYPE 111
TABLE 53 WATER TREATMENT SYSTEMS MARKET, BY TYPE, 2022–2029 (USD MILLION) 111
TABLE 54 WATER TREATMENT SYSTEMS MARKET, BY REGION, 2022–2029 (USD MILLION) 112
6.5.1 CENTRAL WATER DISINFECTION SYSTEMS 112
6.5.1.1 Cost effectiveness and easy maintenance to drive market 112
TABLE 55 WATER TREATMENT SYSTEMS MARKET FOR CENTRAL WATER DISINFECTION SYSTEMS, BY REGION, 2022–2029 (USD MILLION) 112
6.5.2 PORTABLE WATER DISINFECTION SYSTEMS 113
6.5.2.1 User-friendly operations and improved microbiological purity to support segment growth 113
TABLE 56 WATER TREATMENT SYSTEMS MARKET FOR PORTABLE WATER DISINFECTION SYSTEMS, BY REGION, 2022–2029 (USD MILLION) 113
7 PERITONEAL DIALYSIS MARKET, BY PRODUCT & SERVICE 114
7.1 INTRODUCTION 115
TABLE 57 PERITONEAL DIALYSIS MARKET, BY PRODUCT & SERVICE, 2022–2029 (USD BILLION) 115
7.2 PERITONEAL DIALYSIS PRODUCTS 115
TABLE 58 PERITONEAL DIALYSIS MARKET FOR PERITONEAL DIALYSIS PRODUCTS, BY TYPE, 2022–2029 (USD BILLION) 116
TABLE 59 PERITONEAL DIALYSIS MARKET FOR PERITONEAL DIALYSIS PRODUCTS, BY REGION, 2022–2029 (USD BILLION) 116
7.2.1 PERITONEAL DIALYSIS CONCENTRATES/DIALYSATES 116
7.2.1.1 High demand for concentrates to boost segment growth 116
TABLE 60 PERITONEAL DIALYSIS CONCENTRATES/DIALYSATES MARKET, BY REGION, 2022–2029 (USD BILLION) 117
7.2.2 PERITONEAL DIALYSIS MACHINES 117
7.2.2.1 Rising prevalence of chronic diseases in emerging economies to boost adoption 117
TABLE 61 PERITONEAL DIALYSIS MACHINES MARKET, BY REGION, 2022–2029 (USD BILLION) 118
7.2.3 PERITONEAL DIALYSIS CATHETERS 118
7.2.3.1 Favorable reimbursement policies to support market growth 118
TABLE 62 PERITONEAL DIALYSIS CATHETERS MARKET, BY REGION, 2022–2029 (USD BILLION) 119
7.2.4 PERITONEAL DIALYSIS TRANSFER SETS 119
7.2.4.1 Increasing number of patients in emerging economies to aid market growth 119
TABLE 63 PERITONEAL DIALYSIS TRANSFER SETS MARKET, BY REGION, 2022–2029 (USD BILLION) 120
7.2.5 OTHER PERITONEAL DIALYSIS PRODUCTS 120
TABLE 64 OTHER PERITONEAL DIALYSIS PRODUCTS MARKET, BY REGION, 2022–2029 (USD BILLION) 120
7.3 PERITONEAL DIALYSIS SERVICES 121
7.3.1 BETTER PRIVACY AND INCREASED COMFORT OF AT-HOME DIALYSIS TREATMENT TO DRIVE MARKET 121
TABLE 65 PERITONEAL DIALYSIS MARKET FOR PERITONEAL DIALYSIS SERVICES, BY REGION, 2022–2029 (USD BILLION) 121
7.4 PERITONEAL DIALYSIS MARKET, BY MODALITY 121
TABLE 66 PERITONEAL DIALYSIS MARKET, BY MODALITY, 2022–2029 (USD BILLION) 122
7.4.1 CONTINUOUS AMBULATORY PERITONEAL DIALYSIS 122
7.4.1.1 Superior clearance of high-molecular-weight substances to drive market 122
TABLE 67 PERITONEAL DIALYSIS MARKET FOR CONTINUOUS AMBULATORY PERITONEAL DIALYSIS, BY REGION, 2022–2029 (USD BILLION) 122
7.4.2 AUTOMATED PERITONEAL DIALYSIS 123
7.4.2.1 Risk of rapid decline in residual renal functions to limit adoption 123
TABLE 68 PERITONEAL DIALYSIS MARKET FOR AMBULATORY PERITONEAL DIALYSIS, BY REGION, 2022–2029 (USD BILLION) 123
8 HEMODIALYSIS AND PERITONEAL DIALYSIS MARKET, BY DISEASE INDICATION 124
8.1 INTRODUCTION 125
TABLE 69 HEMODIALYSIS AND PERITONEAL DIALYSIS MARKET, BY DISEASE INDICATION, 2022–2029 (USD BILLION) 125
8.2 END-STAGE RENAL DISEASE 125
8.2.1 RISING GERIATRIC POPULATION AND INCREASING PREVALENCE OF DIABETES TO DRIVE MARKET 125
TABLE 70 HEMODIALYSIS AND PERITONEAL DIALYSIS MARKET FOR END-STAGE RENAL DISEASE, BY REGION, 2022–2029 (USD BILLION) 126
8.3 ACUTE KIDNEY INJURY 126
8.3.1 INCREASE IN NUMBER OF HOSPITALIZATIONS TO PROPEL MARKET GROWTH 126
TABLE 71 HEMODIALYSIS AND PERITONEAL DIALYSIS MARKET FOR ACUTE KIDNEY INJURY, BY REGION, 2022–2029 (USD BILLION) 127
8.4 OTHER DISEASES 127
TABLE 72 HEMODIALYSIS AND PERITONEAL DIALYSIS MARKET FOR OTHER DISEASES, BY REGION, 2022–2029 (USD BILLION) 127
9 HEMODIALYSIS AND PERITONEAL DIALYSIS MARKET, BY END USER 128
9.1 INTRODUCTION 129
TABLE 73 HEMODIALYSIS AND PERITONEAL DIALYSIS MARKET, BY END USER, 2022–2029 (USD BILLION) 129
9.2 HOSPITALS 129
9.2.1 IMPROVED FACILITIES AND INCREASED GOVERNMENT SUPPORT TO DRIVE MARKET 129
TABLE 74 HEMODIALYSIS AND PERITONEAL DIALYSIS MARKET FOR HOSPITALS, BY REGION, 2022–2029 (USD BILLION) 130
9.3 INDEPENDENT DIALYSIS CENTERS 130
9.3.1 INCREASED DEMAND FOR ADVANCED DIALYSIS AND END-STAGE RENAL DISEASE TREATMENTS TO PROPEL MARKET GROWTH 130
TABLE 75 HEMODIALYSIS AND PERITONEAL DIALYSIS MARKET FOR INDEPENDENT DIALYSIS MARKET, BY REGION, 2022–2029 (USD BILLION) 131
9.4 HOME CARE SETTINGS 131
9.4.1 LOWER COST AND SHORTER HOSPITAL STAYS TO AID MARKET GROWTH 131
TABLE 76 HEMODIALYSIS AND PERITONEAL DIALYSIS MARKET FOR HOME CARE SETTINGS, BY REGION, 2022–2029 (USD BILLION) 132
9.5 OTHER END USERS 132
TABLE 77 HEMODIALYSIS AND PERITONEAL DIALYSIS MARKET FOR OTHER END USERS, BY REGION, 2022–2029 (USD BILLION) 133
10 HEMODIALYSIS AND PERITONEAL DIALYSIS MARKET, BY REGION 134
10.1 INTRODUCTION 135
TABLE 78 HEMODIALYSIS AND PERITONEAL DIALYSIS MARKET, BY REGION, 2022–2029 (USD BILLION) 135
10.2 NORTH AMERICA 135
10.2.1 NORTH AMERICA: RECESSION IMPACT 136
FIGURE 34 NORTH AMERICA: HEMODIALYSIS AND PERITONEAL DIALYSIS MARKET SNAPSHOT 136
TABLE 79 NORTH AMERICA: HEMODIALYSIS AND PERITONEAL DIALYSIS MARKET, BY COUNTRY, 2022–2029 (USD BILLION) 137
TABLE 80 NORTH AMERICA: HEMODIALYSIS AND PERITONEAL DIALYSIS MARKET FOR HEMODIALYSIS PRODUCTS, BY TYPE, 2022–2029 (USD BILLION) 137
TABLE 81 NORTH AMERICA: HEMODIALYSIS MACHINES MARKET, BY TYPE, 2022–2029 (USD BILLION) 137
TABLE 82 NORTH AMERICA: HEMODIALYSIS CONSUMABLES & SUPPLIES MARKET, BY TYPE, 2022–2029 (USD BILLION) 138
TABLE 83 NORTH AMERICA: DIALYZERS MARKET, BY MATERIAL, 2022–2029 (USD BILLION) 138
TABLE 84 NORTH AMERICA: DIALYZERS MARKET, BY FLUX, 2022–2029 (USD BILLION) 138
TABLE 85 NORTH AMERICA: CONCENTRATES/DIALYSATES MARKET, BY TYPE, 2022–2029 (USD BILLION) 139
TABLE 86 NORTH AMERICA: ACCESS PRODUCTS MARKET, BY TYPE, 2022–2029 (USD BILLION) 139
TABLE 87 NORTH AMERICA: HEMODIALYSIS AND PERITONEAL DIALYSIS MARKET FOR HEMODIALYSIS SERVICES, BY TYPE, 2022–2029 (USD BILLION) 139
TABLE 88 NORTH AMERICA: HEMODIALYSIS MARKET, BY MODALITY, 2022–2029 (USD BILLION) 140
TABLE 89 NORTH AMERICA: WATER TREATMENT SYSTEMS MARKET, BY TYPE, 2022–2029 (USD MILLION) 140
TABLE 90 NORTH AMERICA: HEMODIALYSIS AND PERITONEAL DIALYSIS MARKET FOR PERITONEAL DIALYSIS PRODUCTS, BY TYPE, 2022–2029 (USD BILLION) 140
TABLE 91 NORTH AMERICA: PERITONEAL DIALYSIS MARKET, BY MODALITY, 2022–2029 (USD BILLION) 141
10.2.2 US 141
10.2.2.1 US to account for largest market share during study period 141
TABLE 92 US: MACROECONOMIC INDICATORS 142
TABLE 93 US: HEMODIALYSIS AND PERITONEAL DIALYSIS MARKET FOR HEMODIALYSIS PRODUCTS, BY TYPE, 2022–2029 (USD BILLION) 142
TABLE 94 US: HEMODIALYSIS MACHINES MARKET, BY TYPE, 2022–2029 (USD BILLION) 142
TABLE 95 US: HEMODIALYSIS CONSUMABLES & SUPPLIES MARKET, BY TYPE, 2022–2029 (USD BILLION) 143
TABLE 96 US: HEMODIALYSIS AND PERITONEAL DIALYSIS MARKET FOR HEMODIALYSIS SERVICES, BY TYPE, 2022–2029 (USD BILLION) 143
TABLE 97 US: HEMODIALYSIS MARKET, BY MODALITY, 2022–2029 (USD BILLION) 143
TABLE 98 US: WATER TREATMENT SYSTEMS MARKET, BY TYPE, 2022–2029 (USD BILLION) 144
TABLE 99 US: HEMODIALYSIS AND PERITONEAL DIALYSIS MARKET FOR PERITONEAL DIALYSIS PRODUCTS, BY TYPE, 2022–2029 (USD BILLION) 144
TABLE 100 US: PERITONEAL DIALYSIS MARKET, BY MODALITY, 2022–2029 (USD BILLION) 144
10.2.3 CANADA 145
10.2.3.1 Shortage of dialysis facilities and increased treatment cost to limit market 145
TABLE 101 CANADA: MACROECONOMIC INDICATORS 145
TABLE 102 CANADA: HEMODIALYSIS AND PERITONEAL DIALYSIS MARKET FOR HEMODIALYSIS PRODUCTS, BY TYPE, 2022–2029 (USD BILLION) 146
TABLE 103 CANADA: HEMODIALYSIS MACHINES MARKET, BY TYPE, 2022–2029 (USD BILLION) 146
TABLE 104 CANADA: HEMODIALYSIS CONSUMABLES & SUPPLIES MARKET, BY TYPE, 2022–2029 (USD BILLION) 146
TABLE 105 CANADA: HEMODIALYSIS AND PERITONEAL DIALYSIS MARKET FOR HEMODIALYSIS SERVICES, BY TYPE, 2022–2029 (USD BILLION) 147
TABLE 106 CANADA: HEMODIALYSIS MARKET, BY MODALITY, 2022–2029 (USD BILLION) 147
TABLE 107 CANADA: WATER TREATMENT SYSTEMS MARKET, BY TYPE, 2022–2029 (USD MILLION) 147
TABLE 108 CANADA: HEMODIALYSIS AND PERITONEAL DIALYSIS MARKET FOR PERITONEAL DIALYSIS PRODUCTS, BY TYPE, 2022–2029 (USD BILLION) 148
TABLE 109 CANADA: PERITONEAL DIALYSIS MARKET, BY MODALITY, 2022–2029 (USD BILLION) 148
10.3 EUROPE 148
10.3.1 EUROPE: RECESSION IMPACT 149
TABLE 110 EUROPE: HEMODIALYSIS AND PERITONEAL DIALYSIS MARKET, BY COUNTRY, 2022–2029 (USD BILLION) 149
TABLE 111 EUROPE: HEMODIALYSIS AND PERITONEAL DIALYSIS MARKET FOR HEMODIALYSIS PRODUCTS, BY TYPE, 2022–2029 (USD BILLION) 149
TABLE 112 EUROPE: HEMODIALYSIS MACHINES MARKET, BY TYPE, 2022–2029 (USD BILLION) 150
TABLE 113 EUROPE: HEMODIALYSIS CONSUMABLES & SUPPLIES MARKET, BY TYPE, 2022–2029 (USD BILLION) 150
TABLE 114 EUROPE: HEMODIALYSIS AND PERITONEAL DIALYSIS MARKET FOR HEMODIALYSIS SERVICES, BY TYPE, 2022–2029 (USD BILLION) 150
TABLE 115 EUROPE: HEMODIALYSIS MARKET, BY MODALITY, 2022–2029 (USD BILLION) 151
TABLE 116 EUROPE: WATER TREATMENT SYSTEMS MARKET, BY TYPE, 2022–2029 (USD MILLION) 151
TABLE 117 EUROPE: HEMODIALYSIS AND PERITONEAL DIALYSIS MARKET FOR PERITONEAL DIALYSIS PRODUCTS, BY TYPE, 2022–2029 (USD BILLION) 151
TABLE 118 EUROPE: PERITONEAL DIALYSIS MARKET, BY MODALITY, 2022–2029 (USD BILLION) 152
10.3.2 GERMANY 152
10.3.2.1 Rising number of end-stage renal disease patients to boost market growth 152
TABLE 119 GERMANY: MACROECONOMIC INDICATORS 152
TABLE 120 GERMANY: HEMODIALYSIS AND PERITONEAL DIALYSIS MARKET FOR HEMODIALYSIS PRODUCTS, BY TYPE, 2022–2029 (USD BILLION) 153
TABLE 121 GERMANY: HEMODIALYSIS MACHINES MARKET, BY TYPE, 2022–2029 (USD BILLION) 153
TABLE 122 GERMANY: HEMODIALYSIS CONSUMABLES & SUPPLIES MARKET, BY TYPE, 2022–2029 (USD BILLION) 153
TABLE 123 GERMANY: HEMODIALYSIS AND PERITONEAL DIALYSIS MARKET FOR HEMODIALYSIS SERVICES, BY TYPE, 2022–2029 (USD BILLION) 154
TABLE 124 GERMANY: HEMODIALYSIS MARKET, BY MODALITY, 2022–2029 (USD BILLION) 154
TABLE 125 GERMANY: WATER TREATMENT SYSTEMS MARKET, BY TYPE, 2022–2029 (USD MILLION) 154
TABLE 126 GERMANY: HEMODIALYSIS AND PERITONEAL DIALYSIS MARKET FOR PERITONEAL DIALYSIS PRODUCTS, BY TYPE, 2022–2029 (USD BILLION) 155
TABLE 127 GERMANY: PERITONEAL DIALYSIS MARKET, BY MODALITY, 2022–2029 (USD BILLION) 155
10.3.3 UK 155
10.3.3.1 Increased number of new dialysis centers and technological advancements to support market growth 155
TABLE 128 UK: MACROECONOMIC INDICATORS 156
TABLE 129 UK: HEMODIALYSIS AND PERITONEAL DIALYSIS MARKET FOR HEMODIALYSIS PRODUCTS, BY TYPE, 2022–2029 (USD BILLION) 156
TABLE 130 UK: HEMODIALYSIS MACHINES MARKET, BY TYPE, 2022–2029 (USD BILLION) 157
TABLE 131 UK: HEMODIALYSIS CONSUMABLES & SUPPLIES MARKET, BY TYPE, 2022–2029 (USD BILLION) 157
TABLE 132 UK: HEMODIALYSIS AND PERITONEAL DIALYSIS MARKET FOR HEMODIALYSIS SERVICES, BY TYPE, 2022–2029 (USD BILLION) 157
TABLE 133 UK: HEMODIALYSIS MARKET, BY MODALITY, 2022–2029 (USD BILLION) 158
TABLE 134 UK: WATER TREATMENT SYSTEMS MARKET, BY TYPE, 2022–2029 (USD MILLION) 158
TABLE 135 UK: HEMODIALYSIS AND PERITONEAL DIALYSIS MARKET FOR PERITONEAL DIALYSIS PRODUCTS, BY TYPE, 2022–2029 (USD BILLION) 158
TABLE 136 UK: PERITONEAL DIALYSIS MARKET, BY MODALITY, 2022–2029 (USD BILLION) 159
10.3.4 FRANCE 159
10.3.4.1 High cost of dialysis treatment and variation in reimbursement policies to limit market growth 159
TABLE 137 FRANCE: MACROECONOMIC INDICATORS 159
TABLE 138 FRANCE: HEMODIALYSIS AND PERITONEAL DIALYSIS MARKET FOR HEMODIALYSIS PRODUCTS, BY TYPE, 2022–2029 (USD BILLION) 160
TABLE 139 FRANCE: HEMODIALYSIS MACHINES MARKET, BY TYPE, 2022–2029 (USD BILLION) 160
TABLE 140 FRANCE: HEMODIALYSIS CONSUMABLES & SUPPLIES MARKET, BY TYPE, 2022–2029 (USD BILLION) 160
TABLE 141 FRANCE: HEMODIALYSIS AND PERITONEAL DIALYSIS MARKET FOR HEMODIALYSIS SERVICES, BY TYPE, 2022–2029 (USD BILLION) 161
TABLE 142 FRANCE: HEMODIALYSIS MARKET, BY MODALITY, 2022–2029 (USD BILLION) 161
TABLE 143 FRANCE: WATER TREATMENT SYSTEMS MARKET, BY TYPE, 2022–2029 (USD MILLION) 161
TABLE 144 FRANCE: HEMODIALYSIS AND PERITONEAL DIALYSIS MARKET FOR PERITONEAL DIALYSIS PRODUCTS, BY TYPE, 2022–2029 (USD BILLION) 162
TABLE 145 FRANCE: PERITONEAL DIALYSIS MARKET, BY MODALITY, 2022–2029 (USD BILLION) 162
10.3.5 ITALY 162
10.3.5.1 Increasing research activities and growing patient population with acute renal failure to augment market growth 162
TABLE 146 ITALY: MACROECONOMIC INDICATORS 163
TABLE 147 ITALY: HEMODIALYSIS AND PERITONEAL DIALYSIS MARKET FOR HEMODIALYSIS PRODUCTS, BY TYPE, 2022–2029 (USD BILLION) 163
TABLE 148 ITALY: HEMODIALYSIS MACHINES MARKET, BY TYPE, 2022–2029 (USD BILLION) 163
TABLE 149 ITALY: HEMODIALYSIS CONSUMABLES & SUPPLIES MARKET, BY TYPE, 2022–2029 (USD BILLION) 164
TABLE 150 ITALY: HEMODIALYSIS AND PERITONEAL DIALYSIS MARKET FOR HEMODIALYSIS SERVICES, BY TYPE, 2022–2029 (USD BILLION) 164
TABLE 151 ITALY: HEMODIALYSIS MARKET, BY MODALITY, 2022–2029 (USD BILLION) 164
TABLE 152 ITALY: WATER TREATMENT SYSTEMS MARKET, BY TYPE, 2022–2029 (USD MILLION) 165
TABLE 153 ITALY: HEMODIALYSIS AND PERITONEAL DIALYSIS MARKET FOR PERITONEAL DIALYSIS PRODUCTS, BY TYPE, 2022–2029 (USD BILLION) 165
TABLE 154 ITALY: PERITONEAL DIALYSIS MARKET, BY MODALITY, 2022–2029 (USD BILLION) 165
10.3.6 SPAIN 166
10.3.6.1 Favorable reimbursement scenario to boost market growth 166
TABLE 155 SPAIN: MACROECONOMIC INDICATORS 166
TABLE 156 SPAIN: HEMODIALYSIS AND PERITONEAL DIALYSIS MARKET FOR HEMODIALYSIS PRODUCTS, BY TYPE, 2022–2029 (USD BILLION) 166
TABLE 157 SPAIN: HEMODIALYSIS MACHINES MARKET, BY TYPE, 2022–2029 (USD BILLION) 167
TABLE 158 SPAIN: HEMODIALYSIS CONSUMABLES & SUPPLIES MARKET, BY TYPE, 2022–2029 (USD BILLION) 167
TABLE 159 SPAIN: HEMODIALYSIS AND PERITONEAL DIALYSIS MARKET FOR HEMODIALYSIS SERVICES, BY TYPE, 2022–2029 (USD BILLION) 167
TABLE 160 SPAIN: HEMODIALYSIS MARKET, BY MODALITY, 2022–2029 (USD BILLION) 168
TABLE 161 SPAIN: WATER TREATMENT SYSTEMS MARKET, BY TYPE, 2022–2029 (USD MILLION) 168
TABLE 162 SPAIN: HEMODIALYSIS AND PERITONEAL DIALYSIS MARKET FOR PERITONEAL DIALYSIS PRODUCTS, BY TYPE, 2022–2029 (USD BILLION) 168
TABLE 163 SPAIN: PERITONEAL DIALYSIS MARKET, BY MODALITY, 2022–2029 (USD BILLION) 169
10.3.7 REST OF EUROPE 169
TABLE 164 REST OF EUROPE: HEMODIALYSIS AND PERITONEAL DIALYSIS MARKET FOR HEMODIALYSIS PRODUCTS, BY TYPE, 2022–2029 (USD BILLION) 169
TABLE 165 REST OF EUROPE: HEMODIALYSIS MACHINES MARKET, BY TYPE, 2022–2029 (USD BILLION) 170
TABLE 166 REST OF EUROPE: HEMODIALYSIS CONSUMABLES & SUPPLIES MARKET, BY TYPE, 2022–2029 (USD BILLION) 170
TABLE 167 REST OF EUROPE: HEMODIALYSIS AND PERITONEAL DIALYSIS MARKET FOR HEMODIALYSIS SERVICES, BY TYPE, 2022–2029 (USD BILLION) 170
TABLE 168 REST OF EUROPE: HEMODIALYSIS MARKET, BY MODALITY, 2022–2029 (USD BILLION) 171
TABLE 169 REST OF EUROPE: HEMODIALYSIS AND PERITONEAL DIALYSIS MARKET FOR PERITONEAL DIALYSIS PRODUCTS, BY TYPE, 2022–2029 (USD BILLION) 171
TABLE 170 REST OF EUROPE: PERITONEAL DIALYSIS MARKET, BY MODALITY, 2022–2029 (USD BILLION) 172
10.4 ASIA PACIFIC 172
10.4.1 ASIA PACIFIC: RECESSION IMPACT 172
FIGURE 35 ASIA PACIFIC: HEMODIALYSIS AND PERITONEAL DIALYSIS MARKET SNAPSHOT 173
TABLE 171 ASIA PACIFIC: HEMODIALYSIS AND PERITONEAL DIALYSIS MARKET, BY COUNTRY, 2022–2029 (USD BILLION) 174
TABLE 172 ASIA PACIFIC: HEMODIALYSIS AND PERITONEAL DIALYSIS MARKET FOR HEMODIALYSIS PRODUCTS, BY TYPE, 2022–2029 (USD BILLION) 174
TABLE 173 ASIA PACIFIC: HEMODIALYSIS MACHINES MARKET, BY TYPE, 2022–2029 (USD BILLION) 174
TABLE 174 ASIA PACIFIC: HEMODIALYSIS CONSUMABLES & SUPPLIES MARKET, BY TYPE, 2022–2029 (USD BILLION) 175
TABLE 175 ASIA PACIFIC: HEMODIALYSIS AND PERITONEAL DIALYSIS MARKET FOR HEMODIALYSIS SERVICES, BY TYPE, 2022–2029 (USD BILLION) 175
TABLE 176 ASIA PACIFIC: HEMODIALYSIS MARKET, BY MODALITY, 2022–2029 (USD BILLION) 175
TABLE 177 ASIA PACIFIC: WATER TREATMENT SYSTEMS MARKET, BY TYPE, 2022–2029 (USD MILLION) 176
TABLE 178 ASIA PACIFIC: HEMODIALYSIS AND PERITONEAL DIALYSIS MARKET FOR PERITONEAL DIALYSIS PRODUCTS, BY TYPE, 2022–2029 (USD BILLION) 176
TABLE 179 ASIA PACIFIC: PERITONEAL DIALYSIS MARKET, BY MODALITY, 2022–2029 (USD BILLION) 176
10.4.2 JAPAN 177
10.4.2.1 High prevalence of end-stage renal disease and large geriatric population to support market growth 177
TABLE 180 JAPAN: MACROECONOMIC INDICATORS 177
TABLE 181 JAPAN: HEMODIALYSIS AND PERITONEAL DIALYSIS MARKET FOR HEMODIALYSIS PRODUCTS, BY TYPE, 2022–2029 (USD BILLION) 178
TABLE 182 JAPAN: HEMODIALYSIS MACHINES MARKET, BY TYPE, 2022–2029 (USD BILLION) 178
TABLE 183 JAPAN: HEMODIALYSIS CONSUMABLES & SUPPLIES MARKET, BY TYPE, 2022–2029 (USD BILLION) 178
TABLE 184 JAPAN: HEMODIALYSIS AND PERITONEAL DIALYSIS MARKET FOR HEMODIALYSIS SERVICES, BY TYPE, 2022–2029 (USD BILLION) 179
TABLE 185 JAPAN: HEMODIALYSIS MARKET, BY MODALITY, 2022–2029 (USD BILLION) 179
TABLE 186 JAPAN: WATER TREATMENT SYSTEMS MARKET, BY TYPE, 2022–2029 (USD MILLION) 179
TABLE 187 JAPAN: HEMODIALYSIS AND PERITONEAL DIALYSIS MARKET FOR PERITONEAL DIALYSIS PRODUCTS, BY TYPE, 2022–2029 (USD BILLION) 180
TABLE 188 JAPAN: PERITONEAL DIALYSIS MARKET, BY MODALITY, 2022–2029 (USD BILLION) 180
10.4.3 CHINA 180
10.4.3.1 Increasing prevalence of diabetes and hypertension to drive market 180
TABLE 189 CHINA: MACROECONOMIC INDICATORS 181
TABLE 190 CHINA: HEMODIALYSIS AND PERITONEAL DIALYSIS MARKET FOR HEMODIALYSIS PRODUCTS, BY TYPE, 2022–2029 (USD BILLION) 181
TABLE 191 CHINA: HEMODIALYSIS MACHINES MARKET, BY TYPE, 2022–2029 (USD BILLION) 182
TABLE 192 CHINA: HEMODIALYSIS CONSUMABLES & SUPPLIES MARKET, BY TYPE, 2022–2029 (USD BILLION) 182
TABLE 193 CHINA: HEMODIALYSIS AND PERITONEAL DIALYSIS MARKET FOR HEMODIALYSIS SERVICES, BY TYPE, 2022–2029 (USD BILLION) 182
TABLE 194 CHINA: HEMODIALYSIS MARKET, BY MODALITY, 2022–2029 (USD BILLION) 183
TABLE 195 CHINA: WATER TREATMENT SYSTEMS MARKET, BY TYPE, 2022–2029 (USD MILLION) 183
TABLE 196 CHINA: HEMODIALYSIS AND PERITONEAL DIALYSIS MARKET FOR PERITONEAL DIALYSIS PRODUCTS, BY TYPE, 2022–2029 (USD BILLION) 183
TABLE 197 CHINA: PERITONEAL DIALYSIS MARKET, BY MODALITY, 2022–2029 (USD BILLION) 184
10.4.4 INDIA 184
10.4.4.1 Favorable government initiatives and high prevalence of kidney disease to fuel market growth 184
TABLE 198 INDIA: MACROECONOMIC INDICATORS 185
TABLE 199 INDIA: HEMODIALYSIS AND PERITONEAL DIALYSIS MARKET FOR HEMODIALYSIS PRODUCTS, BY TYPE, 2022–2029 (USD BILLION) 185
TABLE 200 INDIA: HEMODIALYSIS MACHINES MARKET, BY TYPE, 2022–2029 (USD BILLION) 185
TABLE 201 INDIA: HEMODIALYSIS CONSUMABLES & SUPPLIES MARKET, BY TYPE, 2022–2029 (USD BILLION) 186
TABLE 202 INDIA: HEMODIALYSIS AND PERITONEAL DIALYSIS MARKET FOR HEMODIALYSIS SERVICES, BY TYPE, 2022–2029 (USD BILLION) 186
TABLE 203 INDIA: HEMODIALYSIS MARKET, BY MODALITY 2022–2029 (USD BILLION) 186
TABLE 204 INDIA: WATER TREATMENT SYSTEMS MARKET, BY TYPE, 2022–2029 (USD MILLION) 187
TABLE 205 INDIA: HEMODIALYSIS AND PERITONEAL DIALYSIS MARKET FOR PERITONEAL DIALYSIS PRODUCTS, BY TYPE, 2022–2029 (USD MILLION) 187
TABLE 206 INDIA: PERITONEAL DIALYSIS MARKET, BY MODALITY, 2022–2029 (USD BILLION) 187
10.4.5 AUSTRALIA 188
10.4.5.1 Increasing government initiatives about renal care to support market growth 188
TABLE 207 AUSTRALIA: MACROECONOMIC INDICATORS 188
TABLE 208 AUSTRALIA: HEMODIALYSIS AND PERITONEAL DIALYSIS MARKET FOR HEMODIALYSIS PRODUCTS, BY TYPE, 2022–2029 (USD BILLION) 188
TABLE 209 AUSTRALIA: HEMODIALYSIS MACHINES MARKET, BY TYPE, 2022–2029 (USD BILLION) 189
TABLE 210 AUSTRALIA: HEMODIALYSIS CONSUMABLES & SUPPLIES MARKET, BY TYPE, 2022–2029 (USD BILLION) 189
TABLE 211 AUSTRALIA: HEMODIALYSIS AND PERITONEAL DIALYSIS MARKET FOR HEMODIALYSIS SERVICES, BY TYPE, 2022–2029 (USD BILLION) 189
TABLE 212 AUSTRALIA: HEMODIALYSIS MARKET, BY MODALITY, 2022–2029 (USD BILLION) 190
TABLE 213 AUSTRALIA: WATER TREATMENT SYSTEMS MARKET, BY TYPE, 2022–2029 (USD MILLION) 190
TABLE 214 AUSTRALIA: HEMODIALYSIS AND PERITONEAL DIALYSIS MARKET FOR PERITONEAL DIALYSIS PRODUCTS, BY TYPE, 2022–2029 (USD BILLION) 190
TABLE 215 AUSTRALIA: PERITONEAL DIALYSIS MARKET, BY MODALITY, 2022–2029 (USD BILLION) 191
10.4.6 SOUTH KOREA 191
10.4.6.1 Growing geriatric population with chronic kidney disease to propel market growth 191
TABLE 216 SOUTH KOREA: MACROECONOMIC INDICATORS 191
TABLE 217 SOUTH KOREA: HEMODIALYSIS AND PERITONEAL DIALYSIS MARKET FOR HEMODIALYSIS PRODUCTS, BY TYPE, 2022–2029 (USD BILLION) 192
TABLE 218 SOUTH KOREA: HEMODIALYSIS MACHINES MARKET, BY TYPE, 2022–2029 (USD BILLION) 192
TABLE 219 SOUTH KOREA: HEMODIALYSIS CONSUMABLES & SUPPLIES MARKET, BY TYPE, 2022–2029 (USD BILLION) 192
TABLE 220 SOUTH KOREA: HEMODIALYSIS AND PERITONEAL DIALYSIS MARKET FOR HEMODIALYSIS SERVICES, BY TYPE, 2022–2029 (USD BILLION) 193
TABLE 221 SOUTH KOREA: HEMODIALYSIS MARKET, BY MODALITY, 2022–2029 (USD BILLION) 193
TABLE 222 SOUTH KOREA: WATER TREATMENT SYSTEMS MARKET, BY TYPE, 2022–2029 (USD MILLION) 193
TABLE 223 SOUTH KOREA: HEMODIALYSIS AND PERITONEAL DIALYSIS MARKET FOR PERITONEAL DIALYSIS PRODUCTS, BY TYPE, 2022–2029 (USD BILLION) 194
TABLE 224 SOUTH KOREA: PERITONEAL DIALYSIS MARKET, BY MODALITY, 2022–2029 (USD BILLION) 194
10.4.7 REST OF ASIA PACIFIC 194
TABLE 225 REST OF ASIA PACIFIC: HEMODIALYSIS AND PERITONEAL DIALYSIS MARKET FOR HEMODIALYSIS PRODUCTS, BY TYPE, 2022–2029 (USD BILLION) 195
TABLE 226 REST OF ASIA PACIFIC: HEMODIALYSIS MACHINES MARKET, BY TYPE, 2022–2029 (USD BILLION) 195
TABLE 227 REST OF ASIA PACIFIC: HEMODIALYSIS CONSUMABLES & SUPPLIES MARKET, BY TYPE, 2022–2029 (USD BILLION) 195
TABLE 228 REST OF ASIA PACIFIC: DIALYZERS MARKET, BY MATERIAL, 2022–2029 (USD BILLION) 196
TABLE 229 REST OF ASIA PACIFIC: HEMODIALYSIS AND PERITONEAL DIALYSIS MARKET FOR HEMODIALYSIS SERVICES, BY TYPE, 2022–2029 (USD BILLION) 196
TABLE 230 REST OF ASIA PACIFIC: HEMODIALYSIS MARKET, BY MODALITY, 2022–2029 (USD BILLION) 196
TABLE 231 REST OF ASIA PACIFIC: WATER TREATMENT SYSTEMS MARKET, BY TYPE, 2022–2029 (USD MILLION) 197
TABLE 232 REST OF ASIA PACIFIC: HEMODIALYSIS AND PERITONEAL DIALYSIS MARKET FOR PERITONEAL DIALYSIS PRODUCTS, BY TYPE, 2022–2029 (USD BILLION) 197
TABLE 233 REST OF ASIA PACIFIC: PERITONEAL DIALYSIS MARKET, BY MODALITY, 2022–2029 (USD BILLION) 197
10.5 LATIN AMERICA 198
10.5.1 LATIN AMERICA: RECESSION IMPACT 198
TABLE 234 LATIN AMERICA: HEMODIALYSIS AND PERITONEAL DIALYSIS MARKET, BY COUNTRY, 2022–2029 (USD BILLION) 198
TABLE 235 LATIN AMERICA: HEMODIALYSIS AND PERITONEAL DIALYSIS MARKET FOR HEMODIALYSIS PRODUCTS, BY TYPE, 2022–2029 (USD BILLION) 199
TABLE 236 LATIN AMERICA: HEMODIALYSIS MACHINES MARKET, BY TYPE, 2022–2029 (USD BILLION) 199
TABLE 237 LATIN AMERICA: HEMODIALYSIS CONSUMABLES & SUPPLIES MARKET, BY TYPE, 2022–2029 (USD BILLION) 199
TABLE 238 LATIN AMERICA: DIALYZERS MARKET, BY MATERIAL, 2022–2029 (USD BILLION) 200
TABLE 239 LATIN AMERICA: HEMODIALYSIS AND PERITONEAL DIALYSIS MARKET FOR HEMODIALYSIS SERVICES, BY TYPE, 2022–2029 (USD BILLION) 200
TABLE 240 LATIN AMERICA: HEMODIALYSIS MARKET, BY MODALITY, 2022–2029 (USD BILLION) 200
TABLE 241 LATIN AMERICA: WATER TREATMENT SYSTEMS MARKET, BY TYPE, 2022–2029 (USD MILLION) 201
TABLE 242 LATIN AMERICA: HEMODIALYSIS AND PERITONEAL DIALYSIS MARKET FOR PERITONEAL DIALYSIS PRODUCTS, BY TYPE, 2022–2029 (USD BILLION) 201
TABLE 243 LATIN AMERICA: PERITONEAL DIALYSIS MARKET, BY MODALITY, 2022–2029 (USD BILLION) 201
10.5.2 BRAZIL 202
10.5.2.1 Brazil to account for largest share of Latin American market during forecast period 202
TABLE 244 BRAZIL: MACROECONOMIC INDICATORS 202
TABLE 245 BRAZIL: HEMODIALYSIS AND PERITONEAL DIALYSIS MARKET FOR HEMODIALYSIS PRODUCTS, BY TYPE, 2022–2029 (USD BILLION) 202
TABLE 246 BRAZIL: HEMODIALYSIS MACHINES MARKET, BY TYPE, 2022–2029 (USD BILLION) 203
TABLE 247 BRAZIL: HEMODIALYSIS CONSUMABLES & SUPPLIES MARKET, BY TYPE, 2022–2029 (USD BILLION) 203
TABLE 248 BRAZIL: HEMODIALYSIS AND PERITONEAL DIALYSIS MARKET FOR HEMODIALYSIS SERVICES, BY TYPE, 2022–2029 (USD BILLION) 203
TABLE 249 BRAZIL: HEMODIALYSIS MARKET, BY MODALITY, 2022–2029 (USD BILLION) 204
TABLE 250 BRAZIL: WATER TREATMENT SYSTEMS MARKET, BY TYPE, 2022–2029 (USD MILLION) 204
TABLE 251 BRAZIL: HEMODIALYSIS AND PERITONEAL DIALYSIS MARKET FOR PERITONEAL DIALYSIS PRODUCTS, BY TYPE, 2022–2029 (USD BILLION) 204
TABLE 252 BRAZIL: PERITONEAL DIALYSIS MARKET, BY MODALITY, 2022–2029 (USD BILLION) 205
10.5.3 MEXICO 205
10.5.3.1 Increasing patient population and growing middle class population to boost market growth 205
TABLE 253 MEXICO: MACROECONOMIC INDICATORS 205
TABLE 254 MEXICO: HEMODIALYSIS AND PERITONEAL DIALYSIS MARKET FOR HEMODIALYSIS PRODUCTS, BY TYPE, 2022–2029 (USD BILLION) 206
TABLE 255 MEXICO: HEMODIALYSIS MACHINES MARKET, BY TYPE, 2022–2029 (USD BILLION) 206
TABLE 256 MEXICO: HEMODIALYSIS CONSUMABLES & SUPPLIES MARKET, BY TYPE, 2022–2029 (USD BILLION) 206
TABLE 257 MEXICO: HEMODIALYSIS AND PERITONEAL DIALYSIS MARKET FOR HEMODIALYSIS SERVICES, BY TYPE, 2022–2029 (USD BILLION) 207
TABLE 258 MEXICO: HEMODIALYSIS MARKET, BY MODALITY, 2022–2029 (USD BILLION) 207
TABLE 259 MEXICO: WATER TREATMENT SYSTEMS MARKET, BY TYPE, 2022–2029 (USD MILLION) 207
TABLE 260 MEXICO: HEMODIALYSIS AND PERITONEAL DIALYSIS MARKET FOR PERITONEAL DIALYSIS PRODUCTS, BY TYPE, 2022–2029 (USD BILLION) 208
TABLE 261 MEXICO: PERITONEAL DIALYSIS MARKET, BY MODALITY, 2022–2029 (USD BILLION) 208
10.5.4 REST OF LATIN AMERICA 208
TABLE 262 REST OF LATIN AMERICA: HEMODIALYSIS AND PERITONEAL DIALYSIS MARKET FOR HEMODIALYSIS PRODUCTS, BY TYPE, 2022–2029 (USD BILLION) 209
TABLE 263 REST OF LATIN AMERICA: HEMODIALYSIS MACHINES MARKET, BY TYPE, 2022–2029 (USD BILLION) 209
TABLE 264 REST OF LATIN AMERICA: HEMODIALYSIS CONSUMABLES & SUPPLIES MARKET, BY TYPE, 2022–2029 (USD BILLION) 209
TABLE 265 REST OF LATIN AMERICA: HEMODIALYSIS AND PERITONEAL DIALYSIS MARKET FOR HEMODIALYSIS SERVICES, BY TYPE, 2022–2029 (USD BILLION) 210
TABLE 266 REST OF LATIN AMERICA: HEMODIALYSIS MARKET, BY MODALITY, 2022–2029 (USD BILLION) 210
TABLE 267 REST OF LATIN AMERICA: WATER TREATMENT SYSTEMS MARKET, BY TYPE, 2022–2029 (USD MILLION) 210
TABLE 268 REST OF LATIN AMERICA: HEMODIALYSIS AND PERITONEAL DIALYSIS MARKET FOR PERITONEAL DIALYSIS PRODUCTS, BY TYPE, 2022–2029 (USD BILLION) 211
TABLE 269 REST OF LATIN AMERICA: PERITONEAL DIALYSIS MARKET, BY MODALITY, 2022–2029 (USD BILLION) 211
10.6 MIDDLE EAST & AFRICA 211
10.6.1 MIDDLE EAST & AFRICA: RECESSION IMPACT 212
TABLE 270 MIDDLE EAST & AFRICA: HEMODIALYSIS AND PERITONEAL DIALYSIS MARKET FOR HEMODIALYSIS PRODUCTS, BY TYPE, 2022–2029 (USD BILLION) 212
TABLE 271 MIDDLE EAST & AFRICA: HEMODIALYSIS MACHINES MARKET, BY TYPE, 2022–2029 (USD BILLION) 213
TABLE 272 MIDDLE EAST & AFRICA: HEMODIALYSIS CONSUMABLES & SUPPLIES MARKET, BY TYPE, 2022–2029 (USD BILLION) 213
TABLE 273 MIDDLE EAST & AFRICA: HEMODIALYSIS AND PERITONEAL DIALYSIS MARKET FOR HEMODIALYSIS SERVICES, BY TYPE, 2022–2029 (USD BILLION) 213
TABLE 274 MIDDLE EAST & AFRICA: HEMODIALYSIS MARKET, BY MODALITY, 2022–2029 (USD BILLION) 214
TABLE 275 MIDDLE EAST & AFRICA: WATER TREATMENT SYSTEMS MARKET, BY TYPE, 2022–2029 (USD BILLION) 214
TABLE 276 MIDDLE EAST & AFRICA: HEMODIALYSIS AND PERITONEAL DIALYSIS MARKET FOR PERITONEAL DIALYSIS PRODUCTS, BY TYPE, 2022–2029 (USD MILLION) 214
TABLE 277 MIDDLE EAST & AFRICA: PERITONEAL DIALYSIS MARKET, BY MODALITY, 2022–2029 (USD BILLION) 215
10.6.2 GCC COUNTRIES 215
10.6.2.1 Higher disposable income and increased government healthcare expenditure to propel market growth 215
TABLE 278 GCC COUNTRIES: HEMODIALYSIS AND PERITONEAL DIALYSIS MARKET FOR HEMODIALYSIS PRODUCTS, BY TYPE, 2022–2029 (USD BILLION) 215
TABLE 279 GCC COUNTRIES: HEMODIALYSIS MACHINES MARKET, BY TYPE, 2022–2029 (USD BILLION) 216
TABLE 280 GCC COUNTRIES: HEMODIALYSIS CONSUMABLES & SUPPLIES MARKET, BY TYPE, 2022–2029 (USD BILLION) 216
TABLE 281 GCC COUNTRIES: HEMODIALYSIS AND PERITONEAL DIALYSIS MARKET FOR HEMODIALYSIS SERVICES, BY TYPE, 2022–2029 (USD BILLION) 216
TABLE 282 GCC COUNTRIES: HEMODIALYSIS MARKET, BY MODALITY, 2022–2029 (USD BILLION) 217
TABLE 283 GCC COUNTRIES: WATER TREATMENT SYSTEMS MARKET, BY TYPE, 2022–2029 (USD BILLION) 217
TABLE 284 GCC COUNTRIES: HEMODIALYSIS AND PERITONEAL DIALYSIS MARKET FOR PERITONEAL DIALYSIS PRODUCTS, BY TYPE, 2022–2029 (USD MILLION) 217
TABLE 285 GCC COUNTRIES: PERITONEAL DIALYSIS MARKET, BY MODALITY, 2022–2029 (USD BILLION) 218
10.6.3 REST OF MIDDLE EAST & AFRICA 218
TABLE 286 REST OF MIDDLE EAST & AFRICA: HEMODIALYSIS AND PERITONEAL DIALYSIS MARKET FOR HEMODIALYSIS PRODUCTS, BY TYPE, 2022–2029 (USD BILLION) 219
TABLE 287 REST OF MIDDLE EAST & AFRICA: HEMODIALYSIS MACHINES MARKET, BY TYPE, 2022–2029 (USD BILLION) 219
TABLE 288 REST OF MIDDLE EAST & AFRICA: HEMODIALYSIS CONSUMABLES & SUPPLIES MARKET, BY TYPE, 2022–2029 (USD BILLION) 219
TABLE 289 REST OF MIDDLE EAST & AFRICA: HEMODIALYSIS AND PERITONEAL DIALYSIS MARKET FOR HEMODIALYSIS SERVICES, BY TYPE, 2022–2029 (USD BILLION) 220
TABLE 290 REST OF MIDDLE EAST & AFRICA: HEMODIALYSIS MARKET, BY MODALITY, 2022–2029 (USD BILLION) 220
TABLE 291 REST OF MIDDLE EAST & AFRICA: WATER TREATMENT SYSTEMS MARKET, BY TYPE, 2022–2029 (USD BILLION) 220
TABLE 292 REST OF MIDDLE EAST & AFRICA: HEMODIALYSIS AND PERITONEAL DIALYSIS MARKET FOR PERITONEAL DIALYSIS PRODUCTS, BY TYPE, 2022–2029 (USD BILLION) 221
TABLE 293 REST OF MIDDLE EAST & AFRICA: PERITONEAL DIALYSIS MARKET, BY MODALITY, 2022–2029 (USD BILLION) 221
11 COMPETITIVE LANDSCAPE 222
11.1 INTRODUCTION 222
11.2 KEY STRATEGIES/RIGHT-TO-WIN 222
FIGURE 36 HEMODIALYSIS AND PERITONEAL DIALYSIS MARKET: STRATEGIES ADOPTED 223
11.3 REVENUE ANALYSIS 224
FIGURE 37 REVENUE ANALYSIS OF KEY PLAYERS (2019–2023) 224
11.4 MARKET SHARE ANALYSIS 224
FIGURE 38 MARKET SHARE ANALYSIS OF KEY PLAYERS (2023) 225
TABLE 294 HEMODIALYSIS AND PERITONEAL DIALYSIS MARKET: DEGREE OF COMPETITION 225
11.5 COMPANY EVALUATION MATRIX: KEY PLAYERS, 2023 226
11.5.1 STARS 226
11.5.2 PERVASIVE PLAYERS 226
11.5.3 EMERGING LEADERS 226
11.5.4 PARTICIPANTS 227
FIGURE 39 HEMODIALYSIS AND PERITONEAL DIALYSIS MARKET: COMPANY EVALUATION MATRIX (KEY PLAYERS), 2023 227
11.5.5 COMPANY FOOTPRINT: KEY PLAYERS 228
TABLE 295 HEMODIALYSIS AND PERITONEAL DIALYSIS MARKET: OVERALL FOOTPRINT 228
11.5.5.1 Regional footprint 229
TABLE 296 HEMODIALYSIS AND PERITONEAL DIALYSIS MARKET: REGIONAL FOOTPRINT 229
11.5.5.2 Product & service footprint 230
TABLE 297 HEMODIALYSIS AND PERITONEAL DIALYSIS MARKET: PRODUCT & SERVICE FOOTPRINT 230
11.5.5.3 Disease indication footprint 231
TABLE 298 HEMODIALYSIS AND PERITONEAL DIALYSIS MARKET: DISEASE INDICATION FOOTPRINT 231
11.5.5.4 End user footprint 232
TABLE 299 HEMODIALYSIS AND PERITONEAL DIALYSIS MARKET: END USER FOOTPRINT 232
11.6 COMPETITIVE EVALUATION MATRIX: START-UPS/SMES, 2023 233
11.6.1 PROGRESSIVE COMPANIES 233
11.6.2 RESPONSIVE COMPANIES 233
11.6.3 DYNAMIC COMPANIES 233
11.6.4 STARTING BLOCKS 233
FIGURE 40 HEMODIALYSIS AND PERITONEAL DIALYSIS MARKET: COMPANY EVALUATION MATRIX (START-UPS/SMES), 2023 234
11.6.5 COMPETITIVE BENCHMARKING: START-UPS/SMES 235
TABLE 300 HEMODIALYSIS AND PERITONEAL DIALYSIS MARKET: DETAILED LIST OF KEY START-UPS/SMES 235
TABLE 301 HEMODIALYSIS AND PERITONEAL DIALYSIS MARKET: COMPETITIVE BENCHMARKING OF KEY START-UPS/SMES 235
11.7 VALUATION & FINANCIAL METRICS 236
FIGURE 41 EV/EBITDA OF KEY VENDORS 236
11.8 BRAND/PRODUCT COMPARISON 236
TABLE 302 HEMODIALYSIS AND PERITONEAL DIALYSIS MARKET: BRAND/PRODUCT COMPARISON, BY PRODUCT 236
FIGURE 42 BRAND/PRODUCT COMPARATIVE ANALYSIS, BY HEMODIALYSIS AND PERITONEAL DIALYSIS PRODUCT 237
11.9 COMPETITIVE SCENARIO 238
11.9.1 PRODUCT LAUNCHES & APPROVALS 238
TABLE 303 HEMODIALYSIS AND PERITONEAL DIALYSIS MARKET: PRODUCT LAUNCHES & APPROVALS, JANUARY 2021–MARCH 2024 238
11.9.2 DEALS 239
TABLE 304 HEMODIALYSIS AND PERITONEAL DIALYSIS MARKET: DEALS, JANUARY 2021–MARCH 2024 239
11.9.3 EXPANSIONS 240
TABLE 305 HEMODIALYSIS AND PERITONEAL DIALYSIS MARKET: EXPANSIONS, JANUARY 2021–MARCH 2024 240
11.9.4 OTHER DEVELOPMENTS 240
TABLE 306 HEMODIALYSIS AND PERITONEAL DIALYSIS MARKET: OTHER DEVELOPMENTS, JANUARY 2021–MARCH 2024 240
12 COMPANY PROFILES 241
(Business overview, Products/Solutions/Services offered, Recent developments & MnM View)*
12.1 KEY PLAYERS 241
12.1.1 FRESENIUS MEDICAL CARE AG 241
TABLE 307 FRESENIUS MEDICAL CARE AG: COMPANY OVERVIEW 241
FIGURE 43 FRESENIUS MEDICAL CARE AG: COMPANY SNAPSHOT (2022) 242
TABLE 308 FRESENIUS MEDICAL CARE AG: PRODUCTS/SERVICES/SOLUTIONS OFFERED 242
TABLE 309 FRESENIUS MEDICAL CARE AG: PRODUCT LAUNCHES 245
TABLE 310 FRESENIUS MEDICAL CARE AG: DEALS 246
12.1.2 BAXTER 247
TABLE 311 BAXTER: COMPANY OVERVIEW 247
FIGURE 44 BAXTER: COMPANY SNAPSHOT (2023) 248
TABLE 312 BAXTER: PRODUCTS/SERVICES/SOLUTIONS OFFERED 249
TABLE 313 BAXTER: DEALS 251
12.1.3 DAVITA INC. 252
TABLE 314 DAVITA INC.: COMPANY OVERVIEW 252
FIGURE 45 DAVITA INC.: COMPANY SNAPSHOT (2023) 252
TABLE 315 DAVITA INC.: PRODUCTS/SERVICES/SOLUTIONS OFFERED 253
TABLE 316 DAVITA INC.: DEALS 253
TABLE 317 DAVITA INC.: EXPANSIONS 254
12.1.4 NIKKISO CO., LTD. 255
TABLE 318 NIKKISO CO., LTD.: COMPANY OVERVIEW 255
FIGURE 46 NIKKISO CO., LTD.: COMPANY SNAPSHOT (2022) 256
TABLE 319 NIKKISO CO., LTD.: PRODUCTS/SERVICES/SOLUTIONS OFFERED 257
TABLE 320 NIKKISO CO., LTD.: DEALS 258
12.1.5 B. BRAUN SE 259
TABLE 321 B. BRAUN SE: COMPANY OVERVIEW 259
FIGURE 47 B. BRAUN SE: COMPANY SNAPSHOT (2022) 260
TABLE 322 B. BRAUN SE: PRODUCTS/SERVICES/SOLUTIONS OFFERED 260
TABLE 323 B. BRAUN SE: PRODUCT LAUNCHES 262
TABLE 324 B. BRAUN SE: EXPANSIONS 262
12.1.6 MEDTRONIC 264
TABLE 325 MEDTRONIC: COMPANY OVERVIEW 264
FIGURE 48 MEDTRONIC: COMPANY SNAPSHOT (2023) 265
TABLE 326 MEDTRONIC: PRODUCTS/SERVICES/SOLUTIONS OFFERED 266
TABLE 327 MEDTRONIC: DEALS 266
12.1.7 ASAHI KASEI CORPORATION 267
TABLE 328 ASAHI KASEI CORPORATION: COMPANY OVERVIEW 267
FIGURE 49 ASAHI KASEI CORPORATION: COMPANY SNAPSHOT (2022) 268
TABLE 329 ASAHI KASEI CORPORATION: PRODUCTS/SERVICES/SOLUTIONS OFFERED 269
TABLE 330 ASAHI KASEI CORPORATION: DEALS 269
12.1.8 TERUMO CORPORATION 270
TABLE 331 TERUMO CORPORATION: COMPANY OVERVIEW 270
FIGURE 50 TERUMO CORPORATION: COMPANY SNAPSHOT (2022) 270
TABLE 332 TERUMO CORPORATION: PRODUCTS/SERVICES/SOLUTIONS OFFERED 271
TABLE 333 TERUMO CORPORATION: DEALS 271
TABLE 334 TERUMO CORPORATION: OTHER DEVELOPMENTS 271
12.1.9 TORAY MEDICAL CO., LTD. 272
TABLE 335 TORAY MEDICAL CO., LTD.: COMPANY OVERVIEW 272
FIGURE 51 TORAY MEDICAL CO., LTD.: COMPANY SNAPSHOT (2022) 273
TABLE 336 TORAY MEDICAL CO., LTD.: PRODUCTS/SERVICES/SOLUTIONS OFFERED 274
12.1.10 NIPRO CORPORATION 275
TABLE 337 NIPRO CORPORATION: COMPANY OVERVIEW 275
FIGURE 52 NIPRO CORPORATION: COMPANY SNAPSHOT (2022) 276
TABLE 338 NIPRO CORPORATION: PRODUCTS/SERVICES/SOLUTIONS OFFERED 276
TABLE 339 NIPRO CORPORATION: DEALS 277
12.1.11 DIAVERUM AB 278
TABLE 340 DIAVERUM AB: COMPANY OVERVIEW 278
TABLE 341 DIAVERUM AB: PRODUCTS/SERVICES/SOLUTIONS OFFERED 278
12.1.12 DIALIFE SA 279
TABLE 342 DIALIFE SA: COMPANY OVERVIEW 279
TABLE 343 DIALIFE SA: PRODUCTS/SERVICES/SOLUTIONS OFFERED 279
12.1.13 ISOPURE CORP. 280
TABLE 344 ISOPURE CORP.: COMPANY OVERVIEW 280
TABLE 345 ISOPURE CORP.: PRODUCTS/SERVICES/SOLUTIONS OFFERED 280
12.1.14 ROCKWELL MEDICAL, INC. 281
TABLE 346 ROCKWELL MEDICAL, INC.: COMPANY OVERVIEW 281
FIGURE 53 ROCKWELL MEDICAL, INC.: COMPANY SNAPSHOT (2022) 281
TABLE 347 ROCKWELL MEDICAL, INC.: PRODUCTS/SERVICES/SOLUTIONS OFFERED 282
TABLE 348 ROCKWELL MEDICAL, INC.: DEALS 283
12.1.15 BECTON, DICKINSON AND COMPANY 284
TABLE 349 BECTON, DICKINSON AND COMPANY: COMPANY OVERVIEW 284
FIGURE 54 BECTON, DICKINSON AND COMPANY: COMPANY SNAPSHOT (2023) 285
TABLE 350 BECTON, DICKINSON AND COMPANY: PRODUCTS/SERVICES/SOLUTIONS OFFERED 286
TABLE 351 BECTON, DICKINSON AND COMPANY: EXPANSIONS 286
*Details on Business overview, Products/Solutions/Services offered, Recent developments & MnM View might not be captured in case of unlisted companies.
12.2 OTHER PLAYERS 287
12.2.1 JMS CO. LTD. 287
TABLE 352 JMS CO. LTD.: COMPANY OVERVIEW 287
12.2.2 ALLMED MEDICAL PRODUCTS CO., LTD. 288
TABLE 353 ALLMED MEDICAL PRODUCTS CO., LTD.: COMPANY OVERVIEW 288
12.2.3 ATLANTIC BIOMEDICAL 289
TABLE 354 ATLANTIC BIOMEDICAL: COMPANY OVERVIEW 289
12.2.4 ANGIODYNAMICS 290
TABLE 355 ANGIODYNAMICS: COMPANY OVERVIEW 290
12.2.5 AMECATH 291
TABLE 356 AMECATH: COMPANY OVERVIEW 291
12.2.6 COOK 292
TABLE 357 COOK: COMPANY OVERVIEW 292
12.2.7 MEDICAL COMPONENTS INC. 293
TABLE 358 MEDICAL COMPONENTS INC.: COMPANY OVERVIEW 293
12.2.8 POLYMEDICURE 294
TABLE 359 POLYMEDICURE: COMPANY OVERVIEW 294
12.2.9 XYLEM 295
TABLE 360 XYLEM: COMPANY OVERVIEW 295
12.2.10 OUTSET MEDICAL, INC. 296
TABLE 361 OUTSET MEDICAL, INC.: COMPANY OVERVIEW 296
13 APPENDIX 297
13.1 KNOWLEDGESTORE: MARKETSANDMARKETS’ SUBSCRIPTION PORTAL 301
13.2 CUSTOMIZATION OPTIONS 303
13.3 RELATED REPORTS 303
13.4 AUTHOR DETAILS 304